<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940523-2-00058</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> June 22, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> <!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[Docket No. 94N&hyph;0181]</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Fujisawa USA, Inc., et al.; Withdrawal of Approval of 22 Abbreviated New Drug Applications</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Notice. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The Food and Drug Administration (FDA) is withdrawing approval of 22 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> June 22, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Lola E. Batson, Center for Drug Evaluation and Research (HFD&hyph;360), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1038. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The holders of the ANDA's listed in the table in this document have informed FDA that these drug products are no longer marketed and have requested that FDA withdraw approval of the applications. The applicants have also, by their request, waived their opportunity for a hearing. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 3,L2,nj,i1,s15,r85,r68  -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1ANDA no.  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Drug <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Applicant <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=01 g=1 f=1 --> 70&hyph;223 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Sulfamethoxazole and Trimethoprim Concentrate for Injection, USP, 80 milligrams (mg)/milliliters (mL) and 16 mg/mL <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Fujisawa USA, Inc., Parkway North Center, Three Parkway North, Deerfield, IL 60015&hyph;2548. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 70&hyph;411 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Vincristine Sulfate Injection, USP, 1 mg/mL <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 71&hyph;270 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Tolazamide Tablets, 250 mg  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Interpharm, Inc., 3 Fairchild Ave., Plainview, NY 11803. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 71&hyph;271 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Tolazamide Tablets, 500 mg <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 71&hyph;299 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 71&hyph;300 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Sulfamethoxazole and Trimethoprim Tablets, USP, 80 mg/160 mg <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline --> 71&hyph;621 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Cholestyramine Resin Bars <!-- PJG 0012 frnewline -->  (Caramel) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Parke-Davis, 2800 Plymouth Rd., Ann Arbor, MI 48105. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 71&hyph;739 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Cholestyramine Resin Bars <!-- PJG 0012 frnewline -->  (Raspberry) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 83&hyph;147 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Sterile Cortisone Acetate Suspension, USP, 25 mg/mL 50 mg/mL <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Steris Laboratories,Inc., P.O. Box 23160, Pheonix, AZ 85063&hyph;3160. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 84&hyph;356 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Edetate Disodium Injection, <!-- PJG 0012 frnewline -->  USP, 150 mg/mL <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 85&hyph;028 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Hydrocortisone Ointment, USP, 1% <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Clay-Park Labs, Inc., 1700 Bathgate Ave., Bronx, NY 10457. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 85&hyph;663 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Hydrocortisone Lotion, USP, 1%  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 86&hyph;466 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Aminophylline Oral Solution, USP, 105 mg/5 mL  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Fisons Corp., 755 Jefferson Rd., P.O. Box 1710, Rochester, NY 14603&hyph;1710. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 87&hyph;885 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Potassium Chloride for Injection Concentrate, USP <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Fujisawa USA, Inc. Parkway North Center, Three Parkway North, Deerfield, IL <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 87&hyph;912 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Triamcinolone Acetonide Cream, USP, 0.1% <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Pharmafair Inc., 110 Kennedy Drive, Hauppauge, NY 11788 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 87&hyph;921 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Triamcinolone Acetonide Cream, USP, 0.025% <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 87&hyph;922 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Triamcinolone Acetonide Cream, USP, 0.5% <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 88&hyph;032 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Sulfacetamide Sodium and Prednisolone Acetate Ophthalmic Ointment, USP, 0.125% <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 88&hyph;165 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Prednisolone Sodium Phosphate Ophthalmic Solution, USP, 1% <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 88&hyph;385 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Sulfacetamide Sodium Ophthalmic Solution, USP, 30%  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 88&hyph;415 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Prednisolone Sodium Phosphate Ophthalmic Solution, USP, 0.125% <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 89&hyph;914 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Hydrocortisone Acetate Cream, USP, 1%  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Parke-Davis. <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Therefore, under section 505(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(e)) and under authority delegated to the Director, Center for Drug Evaluation and Research (21 CFR 5.82), approval of the ANDA's listed above, and all amendments and supplements thereto, is hereby withdrawn, effective June 22, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: May 10, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Murray M. Lumpkin, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Acting Director, Center for Drug Evaluation and Research. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;12554 Filed 5&hyph;20&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            